Literature DB >> 17334606

Neurodegeneration in schizophrenia: evidence from in vivo neuroimaging studies.

John G Csernansky1.   

Abstract

Although schizophrenia is primarily considered to be a neurodevelopmental disorder, there is a growing consensus that the disorder may also involve neurodegeneration. Recent research using non-invasive neuroimaging techniques, such as magnetic resonance imaging, suggests that some patients with schizophrenia show progressive losses of gray matter in the frontal and temporal lobes of the brain. The cellular mechanisms responsible for such gray matter losses are unknown, but have been hypothesized to involve abnormal increases in apoptosis.

Entities:  

Mesh:

Year:  2007        PMID: 17334606      PMCID: PMC5901218          DOI: 10.1100/tsw.2007.47

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  9 in total

1.  Heat shock protein 70 gene polymorphisms are associated with paranoid schizophrenia in the Polish population.

Authors:  Malgorzata Kowalczyk; Aleksander Owczarek; Renata Suchanek; Monika Paul-Samojedny; Anna Fila-Danilow; Paulina Borkowska; Krzysztof Kucia; Jan Kowalski
Journal:  Cell Stress Chaperones       Date:  2013-07-28       Impact factor: 3.667

Review 2.  Chorioamnionitis, IL-17A, and fetal origins of neurologic disease.

Authors:  Shelley M Lawrence; James L Wynn
Journal:  Am J Reprod Immunol       Date:  2017-12-22       Impact factor: 3.886

Review 3.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

4.  Fronto-temporal dysfunction in schizophrenia: A selective review.

Authors:  John P John
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

5.  Neuroinflammation resulting from covert brain invasion by common viruses - a potential role in local and global neurodegeneration.

Authors:  Jeannine A Majde
Journal:  Med Hypotheses       Date:  2010-03-16       Impact factor: 1.538

6.  Diagnostic Accuracy of Brain-derived Neurotrophic Factor and Nitric Oxide in Patients with Schizophrenia: A pilot study.

Authors:  Vladimir V Djordjević; Dušan Lazarević; Vladan Ćosić; Marinela Z Knežević; Vidosava B Djordjević; Ivana Stojanović
Journal:  J Med Biochem       Date:  2015-12-30       Impact factor: 3.402

7.  Relationships Among Retinal Nerve Fiber Layer Thickness, Vascular Endothelial Growth Factor, and Cognitive Impairment in Patients with Schizophrenia.

Authors:  Yanhong Liu; Jingxu Chen; Lvzhen Huang; Shaoxiao Yan; Qingtao Bian; Fude Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-09       Impact factor: 2.570

8.  Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice.

Authors:  R Barzilay; T Ben-Zur; O Sadan; Z Bren; M Taler; N Lev; I Tarasenko; R Uzan; I Gil-Ad; E Melamed; A Weizman; D Offen
Journal:  Transl Psychiatry       Date:  2011-12-13       Impact factor: 6.222

9.  Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.

Authors:  Saeed Mohammad Al-Asmary; Saeed Kadasah; Misbahul Arfin; Mohammad Tariq; Abdulrahman Al-Asmari
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.